Patent · US Active

Crystalline forms of nicotinamide riboside chloride

US12043616B2 · kind B2 · utility

2Cited by
16References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2022
Grant dateJul 23, 2024
Priority date
Expiry dateSep 5, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.